Investing Ideas
/
South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

JW Lifescience

Market Cap: ₩190.9b

Provides national infusion solutions in South Korea and internationally.

A234080

₩12,360.00

1.7%

2.8%